From: Mediastinal staging lymph node probability map in non-small cell lung cancer
Lymph nodes sampled, N | 358 | |
---|---|---|
Patient studied, N | 116 | |
Age, mean (SD) | 66.2 (10.3) | |
Sex, N (%) | Male | 96 (83%) |
Tobacco, N (%) | Smoker | 50 (43%) |
Former smoker | 61 (53%) | |
Tobacco cumulative dose, median (Q1; Q3) | 43.5 (3;18) | |
Lung disease, N (%) | COPD | 42 (37%) |
ASTHMA | 2 (2%) | |
Interstitial Lung Disease | 2 (2%) | |
Diabetes, N (%) | present | 24 (21%) |
Lung function test, median (Q1; Q3) | FVC % predicted | 90.5 (76.7;107) |
FEV1% predicted | 76.6 (61.7;90.1) | |
FEV1/FVC | 67.1 (57.1;73.0) |